Total trials
65
Active
14
Phase 3
10
Total enrollment
12,193
Pipeline matrix
Showing 9 of 9 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| 177Lu-DOTATOC | — | — | — | — | — | 1 | |
| Capecitabine | — | — | — | — | — | 1 | |
| epirubicin, cyclophosphamide, paclitaxel, carboplatin, pembrolizumab | — | — | — | — | — | 1 | |
| epirubicin, cyclophosphamide, capecitabine, paclitaxel, carboplatin, pembrolizumab | — | — | — | — | — | 1 | |
| Fluorouracil | — | — | — | — | — | 1 | |
| Oxaliplatin | — | — | — | — | — | 1 | |
| Irinotecan | — | — | — | — | — | 1 | |
| Pemigatinib | — | — | — | — | — | 1 | |
| Retifanlimab | — | — | — | — | — | 1 |
Next readouts
- 2026-10-01
- 2026-11-30
- 2027-12-31
- 2035-09
Top conditions
- Colorectal Cancer3
- Breast Cancer3
- Neuroendocrine Tumors2
- Opioid Use2
- Lung Transplant Failure2
- Lung Transplant; Complications2
- Cardiovascular Diseases2
- Metastatic Breast Cancer2
Frequently asked questions about Lund University Hospital
- How many clinical trials does Lund University Hospital have on ClinicalTrials.gov?
- Lund University Hospital is listed as the lead sponsor on 65 clinical trials in ClinicalTrials.gov, 14 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Lund University Hospital's trials are in Phase 3?
- 10 of Lund University Hospital's trials are in Phase 3, spread across 9 active drug programs.
- What therapeutic areas does Lund University Hospital focus on?
- Lund University Hospital's most-studied conditions on ClinicalTrials.gov are Colorectal Cancer, Breast Cancer, Neuroendocrine Tumors, Opioid Use, Lung Transplant Failure.
- When are Lund University Hospital's next clinical trial readouts?
- Lund University Hospital has 4 upcoming primary-completion readouts tracked here; the soonest is “Systemic Targeted Adaptive RadioTherapy of NeuroEndocrine Tumors.”, expected around 2026-10-01.